Question to the Department of Health and Social Care:

To ask the Secretary of State for Health, what steps his Department is taking to ensure that medicines distributed within the UK on European Medicines Agency licence continue to be distributed once the UK leaves the EU.

The Government is very aware of the need to ensure that medicines already on the United Kingdom market, and which were licensed through the European Medicines Agency’s centralised procedure, remain approved for use across the UK after our exit from the European Union. This is not an issue which needs to form part of any negotiation, but will be within the UK’s own competence.